Candriam Eqs L Biotech R GBP Cap

add to virtual portfolio
This fund can be held in
Trading AccountISAJISASIPP

Fund Info

  • Yield History-
  • 3 Year sharpe0.51
  • 3 Year alpha0.47
  • Distribution Typeaccumulation
  • BenchmarkNASDAQ Biotechnology TR USD
  • Legal StructureSICAV
  • Fund Size (month end)SICAV
  • OCF1.10%
  • IA SectorSpecialist
  • Manager GroupCandriam
  • DomicileLuxembourg
  • ISINLU1269736911

Investment Strategy

The objective of the sub-fund is to use discretionary management to benefit from the performance of the market in global equities of companies from the biotechnology sector, and to outperform the benchmark. This sub-fund enables shareholders to invest in a portfolio of global equities in the biotechnology sector. The assets will be invested principally in the equities of companies operating in this sector.

Latest news

Currently there for this fund. Visit our news hub for other news .